Erweiterte Suche

Dr. Colin S. Goldschmidt, MD, ist ein Chief Executive Officer bei Douglass Hanly Moir Pathology Pty Ltd. und ein Chief Executive Officer, MD & Executive Director bei Sonic Healthcare Ltd. Er ist Mitglied des Board of Directors bei Sonic Healthcare Holding Co., Sonic Healthcare Ltd, Health Services Laboratories LLP, Sonic Healthcare USA, Inc, TDL Genetics Ltd. und The Doctors Laboratory Ltd. Dr. Goldschmidt war zuvor als Non-Executive Director bei Independent Practitioner Network Pty Ltd. und als Independent Non-Executive Director bei Silex Systems Ltd. tätig.

Colin Goldschmidt is currently a Director at Basic Food Group LLC.

Gegenwärtig ist Peter Goldschmidt Vorstandsvorsitzender der STADA Arzneimittel AG, Chief Executive Officer von Fougera Pharmaceuticals, Inc. und Präsident von Sandoz, Inc. Außerdem ist er Mitglied des Vorstands der Association for Accessible Medicines. Zuvor war er Head-Marketing bei Novartis Pharma (Schweden), Country President bei Novartis Healthcare Philippines, Inc. und Head-Central & Eastern Europe bei Sandoz International GmbH sowie Head-Sales & Marketing bei Novartis Pharmaceuticals. Peter Goldschmidt erwarb ein Diplom und einen Bachelor-Abschluss an der Universität Münster.

Herr Colin Bell ist Group Chief Compliance Officer bei HSBC Holdings Plc. Er ist Mitglied des Board of Directors bei Quantexa Ltd. und HSBC Bank Plc. Herr Bell war zuvor als Head-Compliance & Operational Risk Control bei UBS Ltd. und als Global Head-Operational Risk Control bei UBS Reorganisation 2005-04 Ltd. tätig.

Colin Grahame Storrie ist Mitglied des Australian Institute of Co. Directors und Mitglied im Vorstand von 7 weiteren Unternehmen. In der Vergangenheit war er Chief Financial Officer bei AMP Ltd. Executive Director bei AMP Group Finance Services Ltd. und Chief Financial Officer für AMP Ltd. (Investment Portfolio) (beides Tochtergesellschaften von AMP Ltd.) und Chief Financial Officer bei Qantas Airways Ltd. Herr Storrie erwarb einen Bachelor-Abschluss an der Universität von Wollongong.

Colin Browne ist Mitglied des Vorstands von Footwear Distributors & Retailers of America und Vorsitzender der American Apparel & Footwear Association sowie Chief Operating Officer von Under Armour, Inc. In der Vergangenheit hatte Herr Browne die Position des Vice President & Managing Director bei VF Corp., Chief Executive Officer-Asia bei Pentland Brands Plc und Executive Vice President-Footwear & Accessories bei der Fung Group inne.

Derzeit ist Colin V. Reed Chairman und Chief Executive Officer von Ryman Hospitality Properties, Inc. Außerdem ist er Mitglied des Vorstands der First Horizon Corp. (Tennessee). In seiner früheren Laufbahn war er Chairman & Chief Executive Officer bei Gaylord Entertainment Co., Chairman bei JCC Holding Co., Chief Financial Officer & Executive Vice President bei Caesars License Co. LLC und leitender Assistent bei Holiday Corp.

Colin Naughton is currently the President-Asia Region at Autoliv, Inc. He previously served as the President at Autoliv Japan Ltd.
and Autoliv Thailand Ltd.
Mr. Naughton completed his undergraduate degree at the National University of Ireland Galway.

Colin Michael Penny is currently the Chief Information Officer & Senior VP-Technology at Hydro One Networks, Inc. He is also currently the Chief Information Officer at Algonquin Power & Utilities Corp.
Previously, he worked as the Director at Canadian Cyber Threat Exchange Cctx from 2016 to 2018.
He also held the position of Chief Information Officer & Senior VP-Technology at Hydro One, Inc. and Hydro One Ltd.
from 2009 to 2018.
Mr. Penny completed his undergraduate degree at Queen's University.

Colin Black ist Chief Operating Officer der CrowdStrike Holdings, Inc. und Chief Operating Officer der CrowdStrike, Inc. (eine Tochtergesellschaft von CrowdStrike Holdings, Inc.). Herr Black ist außerdem Secretary & Director bei The Crowdstrike Foundation. In seiner früheren Laufbahn war er Chief Information Officer bei Kratos Defense & Security Solutions, Inc. und Chief Information Officer bei Cymer, Inc.

Colin Dyer ist ein Geschäftsmann, der WorldWide Retail Exchange LLC gegründet hat und an der Spitze von 6 verschiedenen Unternehmen stand. Herr Dyer ist im Vorstand von Altus Group Ltd., The Executives Club of Chicago, Paramount Group, Inc. und Unibail-Rodamco-Westfield SE (ehemaliger Aufsichtsratsvorsitzender) und Mitglied von The Chicago Club und Mitglied von The Royal Institution of Chartered Surveyors. In der Vergangenheit war Colin Dyer als Non-Executive Director bei Jones Lang LaSalle, Inc. und als Chief Executive Officer von Jones Lang LaSalle Americas, Inc. (eine Tochtergesellschaft von Jones Lang LaSalle, Inc.), Client Manager bei McKinsey & Co., Inc, Aufsichtsratsvorsitzender von Unibail-Rodamco-Westfield NV, Chief Executive Officer von Courtaulds Textiles Plc und Chief Executive Officer von WorldWide Retail Exchange LLC. Herr Dyer erwarb einen Bachelor-Abschluss am Imperial College London und einen MBA am INSEAD.

Derzeit bekleidet Colin Hunt die Position des Chief Executive Officer & Executive Director bei AIB Group Plc und Chief Executive Officer & Director bei Allied Irish Banks Plc. Zuvor war er Research Director bei Goodbody Stockbrokers ULC, Managing Director bei Macquarie Capital Ireland DAC und Head-Trading Research bei Bank of Ireland Group Treasury. Colin Hunt erhielt einen Doktortitel vom University College Cork und einen Bachelor-Abschluss vom Trinity College Dublin.

Derzeit ist Colin Shannon Chairman, President & Chief Executive Officer bei PRA Health Sciences, Inc. und Chairman, President & Chief Executive Officer von Pharmaceutical Research Associates, Inc. sowie President für PRA International Operations, Inc. und President von PRA Holdings, Inc. (die alle Tochtergesellschaften von PRA Health Sciences, Inc. sind). Er ist auch im Vorstand von Pharm Research Associates (UK) Ltd. und IMP Logistics UK Ltd. und Fellow Member bei der Association of Chartered Certified Accountants. Colin Shannon hatte zuvor die Position des Executive VP-Global Clinical Operations bei Pharmaceutical Product Development LLC und Executive VP-Global Clinical Operations bei PPD Development LP inne. Er erhielt einen Hochschulabschluss und einen MBA von der City University London.

Colin L.
Simpson is currently the Chief Financial Officer at Manulife Financial Corp.
He previously worked as the Director-Investor Relations at Aviva Plc from 2013 to 2015, a Research Analyst at Goldman Sachs International from 2008 to 2013, and as the Chief Financial Officer at Aviva Plc in 2022.
He also worked as a Research Analyst at Bear Stearns International Ltd.
and as the Chief Financial Officer at Aviva Canada, Inc. Mr. Simpson completed his undergraduate degree at the University of Cape Town.

Colin Peter Kilty ist Mitglied des Vorstands der Red Deer Regional Health Foundation und Senior VP-Operations, Retail & Commercial Fuels bei Parkland Corp. In der Vergangenheit bekleidete er die Position des Vorsitzenden für Providence Healthcare, des Vorsitzenden der Canadian Independent Petroleum Marketers Association und des Senior Vice President-Dealer Operations bei Canadian Tire Corp. Ltd. und Präsident von Canadian Tire Petroleum, Inc. (eine Tochtergesellschaft von Canadian Tire Corp. Ltd.). Herr Kilty erhielt einen Bachelor-Abschluss von der University of Western Ontario und einen MBA von der Schulich School of Business.

Gegenwärtig ist Colin Bond Non-Executive Chairman bei European ScreeningPort GmbH und Chief Financial Officer der Vifor Pharma AG, Chief Financial Officer der Vifor Pharma Management AG (eine Tochtergesellschaft der Vifor Pharma AG). Er ist auch Mitglied des Verwaltungsrats der Siegfried Holding AG, der Vifor Fresenius Medical Care Renal Pharma Ltd. und der BioPharma Credit PLC sowie Mitglied der Royal Pharmaceutical Society of Great Britain. Colin Bond war zuvor Chief Financial Officer der Evotec SE, Chief Financial Officer der Great Lakes Chemical Corp., Chief Financial Officer der Novelis AG, Chief Financial Officer der Novelis Europe Holdings Ltd, Chief Financial Officer der Jet Aviation Management AG, Chief Financial Officer der Ecolab (Schweiz) GmbH, Wirtschaftsprüfer der PricewaterhouseCoopers LLP, Wirtschaftsprüfer der Arthur Andersen AG und Wirtschaftsprüfer der Procter & Gamble AG. Colin Bond erwarb einen MBA an der London Business School und einen Bachelor-Abschluss an der Universität Aston.

Herr Colin D. Meadows ist ein Senior MD & Head-Private Markets bei Invesco Ltd. Er ist Mitglied des Board of Directors bei Invesco Mortgage Capital, Inc. und Atlantic Trust Co., NA (Georgia). Er erhielt seinen Bachelor-Abschluss von der Andrews University und einen Graduiertenabschluss von der Harvard Law School.

Colin S. Mooney hat die Position des Chief Digital Officer & Senior Vice President bei Robert Half International, Inc.

Colin Moore ist Global Chief Investment Officer & Executive VP bei Ameriprise Financial, Inc. und Global Chief Investment Officer & Executive VP bei Columbia Cent Clo Advisers, LLC, Global Chief Investment Officer bei Columbia Wanger Asset Management LLC, Global Chief Investment Officer bei Columbia Management Investment Advisers LLC und Global Chief Investment Officer bei Columbia Threadneedle Investments (Missouri) (die alle Tochtergesellschaften von Ameriprise Financial, Inc. sind). Colin Moore ist außerdem Senior Vice President von Tri-Continental Corp. und Senior Vice President von Columbia Seligman Premium Technology Growth Fund, Inc. In der Vergangenheit hatte er die Position des Chief Investment Officer bei Columbia Management Advisors, Inc. inne, war Portfoliomanager bei Putnam Investment Management LLC, Director of Research bei Rockefeller & Co, Inc. und Head of Investments bei Banc of America Capital Management LLC.

Colin K. Gruending ist Chief Financial Officer & Executive Vice President von Enbridge, Inc. Herr Gruending ist außerdem Mitglied des Vorstands von Gaz Mtro LNG LP und Noverco, Inc. In seiner früheren Karriere war er Chief Financial Officer für Enbridge Management Services, Inc. und Chief Financial Officer für Enbridge Income Fund Holdings, Inc. Er erwarb einen Bachelor-Abschluss an der University of Saskatchewan.

Colin Richard Day currently works at Premier Foods Plc, as Non-Executive Chairman from 2019, Factory Mutual Insurance Co., as Director from 2021, Meggitt Ltd., as Non-Executive Director from 2015, and various other companies.
Mr. Day also formerly worked at WPP 2012 Ltd., as Independent Non-Executive Director from 2011 to 2013, ABB Ltd., as Finance Director, Imperial Brands Plc, as Non-Executive Director from 2005 to 2007, and various other companies.
Mr. Day received his Masters Business Admin degree from Cranfield School of Management.

Colin J. Meyer ist Chief Research & Development Officer, Executive VP bei Reata Pharmaceuticals, Inc. Er erhielt einen Undergraduate-Abschluss von der University of Virginia, einen Doktortitel von der University of Texas Southwestern Medical Center und einen MBA von der SMU-Cox School of Business.

Colin Kincaid is currently the Chief Product Officer at Casa Systems, Inc. Prior to this, he worked as an Engineering Director at Cisco Systems, Inc. and Maker Communications, Inc. He also held Principal positions at Nexion, Inc., Xedia Corp., and ASCOM Corp.
Mr. Kincaid completed his undergraduate degree at Boston University.

Sophie Goldschmidt is currently the President & Chief Executive Officer at US Ski & Snowboard Team Foundation.
She is also a Director at Rugby International Marketing LLC, Cain Acquisition Corp., and a Governor at International Tennis Hall of Fame, Inc. Her former positions include Chief Executive Officer at Association of Surfing Professionals International LLC from 2017 to 2020, Non-Executive Director at Youth Sport Trust from 2012 to 2018, Group Managing Director at CSM Sport & Entertainment LLP, Non-Executive Director at PGA European Tour from 2012 to 2018, Vice President-Marketing & Sponsorships at Wta Tour, Inc., and Chief Commercial & Marketing Officer at Rugby Football Union from 2011 to 2016.
She received her undergraduate degree from Baylor University.

Mr. Eli Goldschmidt is Executive VP-Communications & Regulations at Israel Corp.
Ltd.
He received his graduate degree from Tel-Aviv University.

Ms. Paula Goldschmidt is Vice President-Business Development at Liola Technologies Ltd.
Ms. Goldschmidt was previously employed as a Director-Technology & Business Development by Intel Corp.
She received her undergraduate degree from The Hebrew University of Jerusalem and a graduate degree from The Hebrew University of Jerusalem.

Mikael Goldschmidt is the founder and CEO of M.
Goldschmidt Capital A since 2007.
He is currently the CEO of Kalypso Ejendomme ApS and Chairman of Inspiration A, Slotshotellet ApS, and Kokkedal Slot ApS.
He is also the Chairman of M.
Goldschmidt Ejendomme.
A since 2005 and MGE Bolig Hillerød P since 2007, and MGE Bolig Hillerød Holding A since 2011.
He previously served as Chairman of Imerco A.

Mr. Goldschmidt was the co-founder of Yozma and the core of its management team since inception in January 1993.
Mr. Goldschmidt led many of Yozma's investments in Communications and Internet companies, including E-sim (NASDAQ: ESIM), CommTouch (NASDAQ: CTCH), Telegate (acquired by Terayon Communications, NASDAQ: TERN), HarmonyCom - recently received an investment from Cisco (NASDAQ: CSCO), and Trellis Photonics - recently received investment from Agilent (NYSE:A) and Enron (NYSE: ENE).
Prior to joining Yozma, Goldschmidt gained extensive experience as head of the Royalties Department at the Office of the Chief Scientist.
In this capacity Mr. Goldschmidt evaluated investments in hundreds of high-tech companies primarily in the fields of Communications, Software, and Microelectronics.
Mr.Goldschmidt served on Conduit's BOD and later as Conduit's VP Corp Dev.
He is an active investor and his recent investments include: Javelin Medical, Nova sight, Imvision technologies, Minovia Theraputics, Tingo Medical, Triple jump, Nanorep (Acquired by logmein).
Mr. Goldschmidt holds a BA degree in Economics and an MBA degree from the Hebrew University of Jerusalem.

James E.
Goldschmidt is currently the President-United States at Sandoz, Inc. and the Chief Business Development Officer at CASI Pharmaceuticals, Inc. Previously, he held positions such as Executive Director-Business Development at Johnson & Johnson, Executive Director-Oncology New Business at Wyeth Pharmaceuticals LLC, Product Director at GSK Plc, and Senior Vice President-Business Development at CASI Pharmaceuticals, Inc. He also served as the Vice President-Business & Commercial Development at TetraLogic Pharmaceuticals Corp., Vice President-Business Development at ImmuneXcite, Inc., and Chief Operating Officer at Macrophage Therapeutics, Inc. Dr. Goldschmidt obtained a graduate degree from Drexel University, an undergraduate degree from Villanova University, and a doctorate degree from Temple University School of Medicine.

Lawrence E.
Goldschmidt is currently the Deputy Chairman at The Jewish Guild for the Blind.

Eliot Goldschmidt worked as a Director at Meridian Capital Group LLC from 2018 to 2021.

Oren Goldschmidt is currently a Managing Director at Pivotus, Inc. He was previously a Managing Director at Umpqua Holdings Corp.
where he worked for Pivotus Ventures Inc.

Nils Goldschmidt currently works at Hamburgisches WeltWirtschaftsInstitut gemeinnützige GmbH, as Research Fellow.

Steven Goldschmidt currently works at Real Estate Board of New York, Inc., as Member-the Executive Cmte & NYRS Masters Program.

Amnon Goldschmidt is currently the Chairman of A.
Goldschmidt Investments Ltd., and a Director at Israel Mezzanine Fund LP, FIMI 2001 Ltd., and Harel Recanati Investment House Ltd.
He previously served as Chairman of Memador Ltd., and as a Director at First Israel Mezzanine Investors Ltd., Solbar Food Technologies Ltd., and FIMI Opportunity 2005 Ltd.
He was also an Independent Director at The First International Bank of Israel Ltd.
Dr. Goldschmidt holds a doctorate from Simon Fraser University, and undergraduate and MBA degrees from The Hebrew University of Jerusalem.

Collene Goldschmidt joined Sanlam Private Equity in 2005 and is financial manager responsible for the financial, administrative and operational activities of the business.
She began her professional career after completing her articles with Grant Thornton International.
In 2000, she joined Sanlam Employee Benefits and Multi Data as an Accountant.
As the Multi Data business grew, she later became responsible for financial reporting of Multi Data.
In 2002, she joined Tellumat Manufacturing as a Financial Accountant and with the sale of the business unit to a US based company, Stratex Networks, became responsible for managing the full accounting function for the company’s South Africa operations.
She has a BCom degree in accounting from UCT and Bcompt (Hons) from Unisa.

Mark R Goldschmidt is currently a Partner at Holland & Knight LLP, and a Member of both the Massachusetts Bar Association and The Colorado Bar Association.
He was previously a Principal at Patton Boggs LLP and an Infantry Officer in The United States Army (District of Columbia).
Goldschmidt received a graduate degree from Boston College in 2002.

Luís Goldschmidt currently works as a Press Relations Contact for Caixa Geral de Depósitos SA.

Barry Goldschmidt worked as a Treasurer at Wyndham Hotels & Resorts, Inc. from 2019 to 2023.

Daniel Goldschmidt is currently a Director at Danish Aerospace Medical Co. A, M.
Goldschmidt Holding A, and Imerco Holding A.
He was formerly a Director at Aquaporin A.

Diana E.
Goldschmidt has been a Director of Umpqua Holdings Corp.
since May 2003 and an Owner of Urban Design Works LLC since 1999.
Currently, she is Vice Chairman of the Oregon Investment Council.
Previously, she was a Member of the Advisory Board of Key Bank from 1997 to 2003 and an Interim Superintendent of the Portland Public School in 1999.
She held various senior human resources and senior operations executive officer positions at Pacific Power & Light Company and Pacific Telecom, Inc.

Nathan Goldschmidt is a Member of The Institute of Chartered Accountants in Australia, and a former Chief Financial Officer at Ingenia Communities Group.
He completed his undergraduate degree at The University of New South Wales.

David J.
Goldschmidt is currently a Partner at Skadden, Arps, Slate, Meagher & Flom LLP since 2011.
He is also a Member of the New York State Bar Association.
Mr. Goldschmidt completed his undergraduate degree at New York University in 1984 and his graduate degree at New York University School of Law in 1987.

Lars Goldschmidt is currently the Chairman of Erhvervsskolernes Forlag, Deputy Chairman of Campus Bornholm, Chairman of Horsens Fjernvarme A, Chairman of TREFOR El-Net Øst A, Director of Bornholms Erhvervsfond, Deputy General Director of Dansk Industri Holding A, Director of VIA University College, Director of European Spallation Source ESS AB, Director of Copenhagen School of Design & Technology, Director of Kea Copenhagen School of Design & Technology, and Member of Danish Council For Technology & Innovation.
He is also a Partner at Goldschmidt Rise & Shine I.
In the past, he served as the Chief Executive Officer & Director of Monberg & Thorsen A, Chairman of the University of Copenhagen, Chairman of Bornholms Energi & Forsyning A, Deputy Director General of Confederation of Danish Industry, and Director of Østkraft A.
He holds a graduate and doctorate degree from the Technical University of Denmark.

Roy Goldschmidt is the founder of Astralink Ltd.
He held the title of Chief Marketing Officer at the company, but is no longer active in that role.

Howard Goldschmidt currently works at American Committee for Shaare Zedek Hospital in Jerusalem, as President & Director.

Lutz Goldschmidt currently works at Licht und Kraft GmbH und Co. KG, as Managing Director.